JFS Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$983K Sell
40,840
-1,154
-3% -$30.2K 0.05% 171
2026
Q1
$1.18M Sell
41,994
-1,799
-4% -$47.9K 0.07% 150
2025
Q4
$1.09M Sell
43,793
-3,897
-8% -$98.3K 0.06% 155
2025
Q3
$1.22M Buy
47,690
+4,485
+10% +$111K 0.07% 151
2025
Q2
$1.05M Sell
43,205
-676
-2% -$15.8K 0.07% 147
2025
Q1
$1.11M Buy
43,881
+1,623
+4% +$42.5K 0.08% 141
2024
Q4
$1.12M Sell
42,258
-3,288
-7% -$89.2K 0.08% 133
2024
Q3
$1.32M Buy
45,546
+71
+0.2% +$2.07K 0.09% 126
2024
Q2
$1.27M Sell
45,475
-1,238
-3% -$34.1K 0.1% 100
2024
Q1
$1.3M Sell
46,713
-1,104
-2% -$30.6K 0.1% 96
2023
Q4
$1.38M Sell
47,817
-381
-0.8% -$11.5K 0.12% 93
2023
Q3
$1.6M Buy
48,198
+947
+2% +$33.5K 0.15% 90
2023
Q2
$1.73M Buy
47,251
+868
+2% +$33.8K 0.16% 88
2023
Q1
$1.89M Sell
46,383
-239
-0.5% -$10.3K 0.18% 84
2022
Q4
$2.39M Sell
46,622
-894
-2% -$42.9K 0.23% 72
2022
Q3
$2.08M Sell
47,516
-300
-0.6% -$14.6K 0.23% 78
2022
Q2
$2.51M Buy
47,816
+508
+1% +$25.9K 0.26% 63
2022
Q1
$2.45M Buy
47,308
+297
+0.6% +$15.4K 0.23% 79
2021
Q4
$2.78M Buy
47,011
+2,514
+6% +$125K 0.26% 74
2021
Q3
$1.91M Buy
44,497
+320
+0.7% +$14.2K 0.2% 83
2021
Q2
$1.73M Buy
44,177
+61
+0.1% +$2.37K 0.26% 61
2021
Q1
$1.6M Sell
44,116
-1,041
-2% -$37K 0.33% 58
2020
Q4
$1.66M Sell
45,157
-2,857
-6% -$105K 0.35% 58
2020
Q3
$1.67M Buy
48,014
+4
+0% +$140 0.4% 53
2020
Q2
$1.49M Sell
48,010
-6,950
-13% -$236K 0.39% 54
2020
Q1
$1.7M Buy
54,960
+2,258
+4% +$76.9K 0.51% 48
2019
Q4
$1.96M Sell
52,702
-429
-0.8% -$15.3K 0.48% 51
2019
Q3
$1.81M Sell
53,131
-1,173
-2% -$42.7K 0.46% 51
2019
Q2
$2.23M Buy
54,304
+2
+0% +$79 0.56% 43
2019
Q1
$2.19M Sell
54,302
-1,496
-3% -$59.9K 0.57% 40
2018
Q4
$2.31M Sell
55,798
-2,193
-4% -$91K 0.62% 39
2018
Q3
$2.42M Buy
57,991
+66
+0.1% +$2.54K 0.62% 33
2018
Q2
$1.99M Sell
57,925
-218
-0.4% -$7.45K 0.53% 40
2018
Q1
$1.96M Sell
58,143
-591
-1% -$20.3K 0.52% 42
2017
Q4
$2.02M Buy
58,734
+179
+0.3% +$6.1K 0.49% 43
2017
Q3
$1.98M Buy
58,555
+5,864
+11% +$188K 0.51% 43
2017
Q2
$1.68M Sell
52,691
-1,305
-2% -$41.2K 0.46% 53
2017
Q1
$1.66M Hold
53,996
0.45% 55
2016
Q4
$1.66M Sell
53,996
-2,258
-4% -$68.9K 0.45% 55
2016
Q3
$1.81M Sell
56,254
-90
-0.2% -$3.01K 0.52% 52
2016
Q2
$1.88M Sell
56,344
-116
-0.2% -$3.7K 0.52% 49
2016
Q1
$1.59M Sell
56,460
-1,826
-3% -$52.2K 0.47% 52
2015
Q4
$1.78M Buy
58,286
+2,543
+5% +$80K 0.51% 40
2015
Q3
$1.66M Sell
55,743
-2,281
-4% -$73.1K 0.73% 34
2015
Q2
$1.85M Sell
58,024
-12
-0% -$391 0.95% 22
2015
Q1
$1.92M Sell
58,036
-343
-0.6% -$10.9K 0.9% 23
2014
Q4
$1.73M Buy
58,379
+5,996
+11% +$172K 0.27% 25
2014
Q3
$1.47M Sell
52,383
-8,509
-14% -$239K 0.26% 24
2014
Q2
$1.72M Sell
60,892
-154
-0.3% -$4.39K 0.31% 24
2014
Q1
$1.86M Sell
61,046
-324
-0.5% -$9.66K 1.03% 23
2013
Q4
$1.78M Buy
61,370
+198
+0.3% +$5.76K 0.78% 28
2013
Q3
$1.67M Sell
61,172
-371
-0.6% -$10.1K 0.78% 29
2013
Q2
$1.64M Buy
+61,543
New +$1.7M 0.82% 28

Other funds holding PFE

JFS Wealth Advisors's PFE Position: Q2 2026 in Review

JFS Wealth Advisors reduced its Pfizer (PFE) stake by 2.7% in Q2 2026, selling an estimated $30.2K and leaving 40,840 shares worth $983K. The position accounts for 0.05% of the portfolio, ranked #171.

JFS Wealth Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.78M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • JFS Wealth Advisors held 40,840 shares of Pfizer worth $983K as of Q2 2026.
  • JFS Wealth Advisors sold 1,154 Pfizer shares in Q2 2026, an estimated $30.2K.
  • Pfizer made up 0.05% of JFS Wealth Advisors's portfolio in Q2 2026, its #171 holding.
  • JFS Wealth Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • JFS Wealth Advisors's Pfizer position peaked at $2.78M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.